

13 Apr 2022
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf

26 Apr 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20210426005043/en/Real-world-evidence-demonstrates-that-risedronate-GR-Actonel%C2%AE-GR-has-superior-outcomes-for-fracture-risk-reduction-in-patients-with-osteoporosis-compared-to-immediate-release-oral-bisphosphonates

14 Sep 2018
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203822

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090831

28 Nov 2016
// FDA
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203533

22 Oct 2016
// FDA
https://www.pharmacompass.com/pdf/news/aurobindos-generic-risedronate-sodium-received-approval-in-us-1477569051.pdf